304 filings
Page 8 of 16
6-K
1dqb4 hktq
14 Mar 17
GW Pharmaceuticals Announces Results of Annual General Meeting
12:00am
6-K
vxbl43micp8
7 Mar 17
GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director - UK
12:00am
SC 13G/A
kocej6z
14 Feb 17
GW Pharmaceuticals PLC
12:00am
SC 13G/A
mbfe7h0
14 Feb 17
Beneficial ownership report (amended)
12:00am
SC 13G/A
1yvk9kbfy
14 Feb 17
GW Pharmaceuticals PLC
12:00am
SC 13G
cg2dw70ystgja y0lo0
14 Feb 17
GW Pharmaceuticals PLC
12:00am
6-K
i23ila
13 Feb 17
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt
12:00am
SC 13G/A
8qve7fd
13 Feb 17
GW Pharmaceuticals PLC
12:00am
6-K
64dihm9j
7 Feb 17
GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational
12:00am
6-K
dhngcqajp5fz6qh h8u1
9 Jan 17
Current report (foreign)
12:00am
CT ORDER
c8jrcn
22 Dec 16
Confidential treatment order
12:00am
6-K
w9v skicl6r
20 Dec 16
Current report (foreign)
12:00am
6-K
ll8tfgk3c1a
5 Dec 16
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress
12:00am
6-K
1t8zc iji
3 Nov 16
Current report (foreign)
12:00am
6-K
4vxwfk8kspe
26 Oct 16
Current report (foreign)
12:00am
6-K
nwslhnybx2vbl9l 78y
19 Oct 16
GW Pharmaceuticals plc Announces Intention to Continue Trading Exclusively on NASDAQ and Planned Cancellation of Trading of Ordinary Shares on AIM
12:00am
6-K
t0w34dyzt
7 Oct 16
Current report (foreign)
12:00am
6-K
r525284h30j2f38q0amn
26 Sep 16
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
ig3vn
14 Sep 16
Current report (foreign)
12:00am